Chemoprevention of Oral Dysplasia by Black Raspberries

黑树莓化学预防口腔发育不良

基本信息

  • 批准号:
    6762326
  • 负责人:
  • 金额:
    $ 20.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-08-06 至 2006-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Despite efforts to improve therapy, five year survival rates for patients with oral squamous cell carcinoma (SCC) remain discouragingly low. Clearly, early detection combined with local intervention strategies such as chemoprevention prior to oral SCC development could dramatically improve clinical outcomes. The oral cavity is an optimal site for a human chemoprevention trial, as these tissues can be visually monitored. Also, oral tissues are amenable to topical applications of chemopreventive agents, which markedly increases the therapeutic agent concentrations at the target site. Recent studies from our laboratories have demonstrated that black raspberries possess chemopreventive properties at both the in vitro and in vivo levels. Dietary administration of lyophilized black raspberries successfully inhibited carcinogenesis in both rat and hamster model systems. In addition, black raspberry extract treated immortalized human oral keratinocytes show a reduction in both proliferation and expression of pro-angiogenic and pro-inflammatory molecules while retaining comparable viabilities as control cultures. These data suggest that black raspberries' antitumorigenic effects reflect an ability to initiate terminal differentiation and/or apoptotic signaling pathways. Our Phase I human clinical trials have also confirmed that dietary administration of high dosages of lyophilized black raspberries is well tolerated in humans. Collectively, these data imply that black raspberries are highly promising agents for human clinical chemoprevention trials. We hypothesize that local delivery of freeze-dried black raspberries (FBR), using a bioadhesive gel, will prevent recurrence, inhibit progression and induce regression of oral epithelial dysplasia. The effects of local application of freeze-dried black raspberries on dysplastic lesions of human oral epithelium will be assessed by the following experimental parameters in pretreated and post-treated human biopsies: i) clinical appearance and light microscopic diagnosis, ii) expression of molecular biomarkers associated with premalignancy [DNA ploidy, indices of proliferation, expression of the proangiogenic cytokine (VEGF)], iii) expression of molecular biomarkers associated with normal maturation (return to diploid DNA content), terminal differentiation (Ioricrin and fillagrin) and apoptosis (caspase-3, regulated nuclear fragmentation). This experimental design (comparison of pretreatment and post-treatments tissues) permits each patient to serve as their own internal control.
描述(由申请人提供):尽管努力改善治疗,但口服鳞状细胞癌(SCC)患者的五年存活率仍然令人沮丧。显然,早期检测与局部干预策略相结合,例如口服SCC发育前的化学预防策略可以大大改善临床结果。口腔是人类化学预防试验的最佳部位,因为可以在视觉上监测这些组织。同样,口腔组织适合化学预防剂的局部应用,这显着增加了目标部位的治疗剂浓度。我们实验室的最新研究表明,黑色覆盆子在体外和体内均具有化学预防特性。冻干的黑色覆盆子的饮食给药成功地抑制了大鼠和仓鼠模型系统中的癌变。此外,黑色覆盆子提取物处理过的永生的人口腔角质形成细胞显示,促血管生成和促炎分子的增殖和表达均降低,同时保留了可比较的生存能力作为对照培养物。这些数据表明,黑色覆盆子的抗肿瘤效应反映了启动末端分化和/或凋亡信号通路的能力。我们的I期人类临床试验还证实,饮食中的高剂量高剂量的黑色覆盆子在人类中的耐受性良好。总的来说,这些数据表明,黑色覆盆子是人类临床化学预防试验的高度有希望的药物。我们假设使用生物粘附性凝胶局部递送冻干的黑色覆盆子(FBR)将防止复发,抑制进展并诱导口腔上皮发育不良的回归。 The effects of local application of freeze-dried black raspberries on dysplastic lesions of human oral epithelium will be assessed by the following experimental parameters in pretreated and post-treated human biopsies: i) clinical appearance and light microscopic diagnosis, ii) expression of molecular biomarkers associated with premalignancy [DNA ploidy, indices of proliferation, expression of the proangiogenic cytokine (VEGF),iii)与正常成熟(返回二倍体DNA含量),末端分化(Ioricrin和Fillagrin)和凋亡(caspase-3,调节的核碎片)相关的分子生物标志物的表达。这种实验设计(对预处理和治疗后组织的比较)允许每个患者作为自己的内部控制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Susan R Mallery其他文献

Susan R Mallery的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Susan R Mallery', 18)}}的其他基金

Multidisciplinary Research Training in Dental, Oral, and Craniofacial Sciences (MARTDOCS)
牙科、口腔和颅面科学多学科研究培训 (MARTDOCS)
  • 批准号:
    10711411
  • 财政年份:
    2023
  • 资助金额:
    $ 20.18万
  • 项目类别:
Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention
用于口腔鳞癌化学预防的纳米颗粒释放口腔薄膜的配方、评估和 0 期试验
  • 批准号:
    10540811
  • 财政年份:
    2021
  • 资助金额:
    $ 20.18万
  • 项目类别:
Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention
用于口腔鳞癌化学预防的纳米颗粒释放口腔薄膜的配方、评估和 0 期试验
  • 批准号:
    10359559
  • 财政年份:
    2021
  • 资助金额:
    $ 20.18万
  • 项目类别:
Assessment of Chemopreventive Effects of a Mucoadhesive Fenretinide Patch on Premalignant Oral Epithelial Lesions
粘膜粘附芬维A胺贴剂对口腔癌前上皮病变的化学预防作用评估
  • 批准号:
    10321591
  • 财政年份:
    2019
  • 资助金额:
    $ 20.18万
  • 项目类别:
Assessment of Chemopreventive Effects of a Mucoadhesive Fenretinide Patch on Premalignant Oral Epithelial Lesions
粘膜粘附芬维A胺贴剂对口腔癌前上皮病变的化学预防作用评估
  • 批准号:
    10542711
  • 财政年份:
    2019
  • 资助金额:
    $ 20.18万
  • 项目类别:
Evaluation of locally-delivered fenretinide and black raspberries for oral cancer
局部给药芬维A胺和黑树莓治疗口腔癌的评价
  • 批准号:
    8392351
  • 财政年份:
    2012
  • 资助金额:
    $ 20.18万
  • 项目类别:
Evaluation of locally-delivered fenretinide and black raspberries for oral cancer
局部给药芬维A胺和黑树莓治疗口腔癌的评价
  • 批准号:
    8523810
  • 财政年份:
    2012
  • 资助金额:
    $ 20.18万
  • 项目类别:
Evaluation of locally-delivered fenretinide and black raspberries for oral cancer
局部给药芬维A胺和黑树莓治疗口腔癌的评价
  • 批准号:
    9091491
  • 财政年份:
    2012
  • 资助金额:
    $ 20.18万
  • 项目类别:
Evaluation of locally-delivered fenretinide and black raspberries for oral cancer
局部给药芬维A胺和黑树莓治疗口腔癌的评价
  • 批准号:
    8867171
  • 财政年份:
    2012
  • 资助金额:
    $ 20.18万
  • 项目类别:
Evaluation of locally-delivered fenretinide and black raspberries for oral cancer
局部给药芬维A胺和黑树莓治疗口腔癌的评价
  • 批准号:
    8686793
  • 财政年份:
    2012
  • 资助金额:
    $ 20.18万
  • 项目类别:

相似国自然基金

生物产品多组分分离的动态吸附膜和静态吸附膜集成技术研究
  • 批准号:
    20976175
  • 批准年份:
    2009
  • 资助金额:
    9.0 万元
  • 项目类别:
    面上项目
转基因植物产品电化学生物传感器
  • 批准号:
    20375020
  • 批准年份:
    2003
  • 资助金额:
    32.0 万元
  • 项目类别:
    面上项目

相似海外基金

Immunological, serologic, and imaging biomarker predictors of flare in pediatric spondyloarthritis
小儿脊柱关节炎发作的免疫学、血清学和影像学生物标志物预测因子
  • 批准号:
    10310664
  • 财政年份:
    2021
  • 资助金额:
    $ 20.18万
  • 项目类别:
Interaction of HTLV-1 Tax & Hbz in Transformation
HTLV-1 税的相互作用
  • 批准号:
    10189192
  • 财政年份:
    2021
  • 资助金额:
    $ 20.18万
  • 项目类别:
Interaction of HTLV-1 Tax & Hbz in Transformation
HTLV-1 税的相互作用
  • 批准号:
    10403617
  • 财政年份:
    2021
  • 资助金额:
    $ 20.18万
  • 项目类别:
Immunological, serologic, and imaging biomarker predictors of flare in pediatric spondyloarthritis
小儿脊柱关节炎发作的免疫学、血清学和影像学生物标志物预测因子
  • 批准号:
    10491257
  • 财政年份:
    2021
  • 资助金额:
    $ 20.18万
  • 项目类别:
Assessing Predictors of Response to Anti-Tumor Necrosis Alpha Therapy in Early Crohns Disease
评估早期克罗恩病抗肿瘤坏死α疗法反应的预测因素
  • 批准号:
    10324596
  • 财政年份:
    2019
  • 资助金额:
    $ 20.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了